Form 20-F ☑
|
Form 40-F ☐
|
Yes ☐
|
No ☑
|
EXFO INC.
|
|
By: /s/ Germain Lamonde
Name: Germain Lamonde
Title: President and Chief Executive Officer
|
|
§
|
Sales increase 5.4% year-over-year to US$60.9 million
|
§
|
Adjusted EBITDA improves 18.8% year-over-year to US$5.3 million
|
§
|
Cash flows from operations of US$2.3 million raises cash position to US$46.3 million
|
Q3 2016
|
Q2 2016
|
Q3 2015
|
||||||||||
Physical-layer sales
|
$
|
42,074
|
$
|
32,582
|
$
|
38,167
|
||||||
Protocol-layer sales
|
19,260
|
21,990
|
20,492
|
|||||||||
Foreign exchange losses on forward exchange contracts
|
(438
|
)
|
(975
|
)
|
(878
|
)
|
||||||
Total sales
|
$
|
60,896
|
$
|
53,597
|
$
|
57,781
|
||||||
Physical-layer bookings
|
$
|
41,797
|
$
|
34,873
|
$
|
38,534
|
||||||
Protocol-layer bookings
|
18,389
|
25,805
|
21,593
|
|||||||||
Foreign exchange losses on forward exchange contracts
|
(438
|
)
|
(975
|
)
|
(878
|
)
|
||||||
Total bookings
|
$
|
59,748
|
$
|
59,703
|
$
|
59,249
|
||||||
Book-to-bill ratio
|
0.98
|
1.11
|
1.03
|
|||||||||
Gross margin*
|
$
|
37,016
|
$
|
34,693
|
$
|
35,500
|
||||||
60.8
|
%
|
64.7
|
%
|
61.4
|
%
|
|||||||
Other selected information:
|
||||||||||||
IFRS net earnings
|
$
|
919
|
$
|
3,963
|
$
|
563
|
||||||
Amortization of intangible assets
|
$
|
294
|
$
|
286
|
$
|
444
|
||||||
Stock-based compensation costs
|
$
|
386
|
$
|
314
|
$
|
374
|
||||||
Net income tax effect of the above items
|
$
|
(31
|
)
|
$
|
(30
|
)
|
$
|
(49
|
)
|
|||
Foreign exchange (gain) loss
|
$
|
957
|
$
|
(1,101
|
)
|
$
|
175
|
|||||
Adjusted EBITDA*
|
$
|
5,301
|
$
|
5,280
|
$
|
4,462
|
·
|
Sales. In the third quarter of 2016, sales were particularly robust within EXFO's optical and transport product lines which are benefiting from a 100G investment cycle. From a geographic standpoint, 59% of sales originated from the Americas, 22% from EMEA and 19% from Asia-Pacific. EXFO's top customer accounted for 5.0% of sales, while the top three represented 14.7%.
|
·
|
Profitability. Adjusted EBITDA improved 18.8% year-over-year to US$5.3 million in the third quarter of 2016. After nine months into fiscal 2016, EXFO generated adjusted EBITDA of US$15.9 million, or 9.3% of sales. The company also reported US$2.3 million in cash flows from operating activities in the third quarter and US$20.8 million after nine months into fiscal 2016.
|
·
|
Innovation. EXFO launched four key new solutions during the third quarter of 2016, including the LTB-8, a multi-module test platform dedicated to high-speed testing in lab and manufacturing environments; a 100G Power Blazer test module that can be swapped between the LTB-8 and FTB-2 Pro platforms to ease the transition between lab and field testing; and EXFO added two 100G portable testers to its NetBlazer product family in order to address growing turn-up and troubleshooting requirements for metro networks and data center interconnects (DCIs).
|
Q3 2016
|
Q2 2016
|
Q3 2015
|
||||||||||
IFRS net earnings for the period
|
$
|
919
|
$
|
3,963
|
$
|
563
|
||||||
Add (deduct):
|
||||||||||||
Depreciation of property, plant and equipment
|
958
|
924
|
1,163
|
|||||||||
Amortization of intangible assets
|
294
|
286
|
444
|
|||||||||
Interest and other (income) expenses
|
(309
|
)
|
(470
|
)
|
36
|
|||||||
Income taxes
|
2,096
|
1,364
|
1,707
|
|||||||||
Stock-based compensation costs
|
386
|
314
|
374
|
|||||||||
Foreign exchange (gain) loss
|
957
|
(1,101
|
)
|
175
|
||||||||
Adjusted EBITDA for the period
|
$
|
5,301
|
$
|
5,280
|
$
|
4,462
|
||||||
Adjusted EBITDA in percentage of sales
|
8.7
|
%
|
9.9
|
%
|
7.7
|
%
|
As at
May 31,
2016
|
As at
August 31,
2015
|
|||||||
Assets
|
||||||||
Current assets
|
||||||||
Cash
|
$
|
42,273
|
$
|
25,864
|
||||
Short-term investments
|
4,039
|
1,487
|
||||||
Accounts receivable
|
||||||||
Trade
|
44,288
|
48,068
|
||||||
Other
|
2,510
|
2,384
|
||||||
Income taxes and tax credits recoverable
|
4,263
|
3,855
|
||||||
Inventories
|
34,939
|
27,951
|
||||||
Prepaid expenses
|
3,235
|
2,801
|
||||||
135,547
|
112,410
|
|||||||
Tax credits recoverable
|
34,320
|
35,625
|
||||||
Property, plant and equipment
|
36,007
|
35,695
|
||||||
Intangible assets
|
3,541
|
4,096
|
||||||
Goodwill
|
21,938
|
21,860
|
||||||
Deferred income tax assets
|
7,973
|
8,900
|
||||||
Other assets
|
691
|
416
|
||||||
$
|
240,017
|
$
|
219,002
|
|||||
Liabilities
|
||||||||
Current liabilities
|
||||||||
Bank loan
|
$
|
455
|
$
|
–
|
||||
Accounts payable and accrued liabilities
|
39,022
|
34,126
|
||||||
Provisions
|
336
|
427
|
||||||
Income taxes payable
|
421
|
779
|
||||||
Deferred revenue
|
10,729
|
7,647
|
||||||
50,963
|
42,979
|
|||||||
Deferred revenue
|
4,929
|
2,957
|
||||||
Deferred income tax liabilities
|
2,734
|
1,524
|
||||||
Other liabilities
|
195
|
791
|
||||||
58,821
|
48,251
|
|||||||
Shareholders' equity
|
||||||||
Share capital (note 5)
|
86,826
|
86,045
|
||||||
Contributed surplus
|
17,635
|
17,778
|
||||||
Retained earnings
|
125,581
|
118,933
|
||||||
Accumulated other comprehensive loss
|
(48,846
|
)
|
(52,005
|
)
|
||||
181,196
|
170,751
|
|||||||
$
|
240,017
|
$
|
219,002
|
Three months
ended
May 31, 2016
|
Nine months
ended
May 31, 2016
|
Three months
ended
May 31, 2015
|
Nine months
ended
May 31, 2015
|
|||||||||||||
Sales
|
$
|
60,896
|
$
|
169,725
|
$
|
57,781
|
$
|
165,495
|
||||||||
Cost of sales (1) (note 6)
|
23,880
|
62,921
|
22,281
|
63,064
|
||||||||||||
Selling and administrative (note 6)
|
20,798
|
60,615
|
20,489
|
61,689
|
||||||||||||
Net research and development (note 6)
|
11,303
|
31,398
|
10,923
|
33,087
|
||||||||||||
Depreciation of property, plant and equipment (note 6)
|
958
|
2,857
|
1,163
|
3,664
|
||||||||||||
Amortization of intangible assets (note 6)
|
294
|
880
|
444
|
2,561
|
||||||||||||
Interest and other (income) expense
|
(309
|
)
|
(716
|
)
|
36
|
(216
|
)
|
|||||||||
Foreign exchange (gain) loss
|
957
|
(454
|
)
|
175
|
(4,787
|
)
|
||||||||||
Earnings before income taxes
|
3,015
|
12,224
|
2,270
|
6,433
|
||||||||||||
Income taxes (note 7)
|
2,096
|
5,576
|
1,707
|
3,458
|
||||||||||||
Net earnings for the period
|
$
|
919
|
$
|
6,648
|
$
|
563
|
$
|
2,975
|
||||||||
Basic and diluted net earnings per share
|
$
|
0.02
|
$
|
0.12
|
$
|
0.01
|
$
|
0.05
|
||||||||
Basic weighted average number of shares outstanding (000s)
|
53,940
|
53,894
|
53,861
|
57,804
|
||||||||||||
Diluted weighted average number of shares outstanding (000s) (note 8)
|
54,813
|
54,655
|
54,549
|
58,453
|
Three months
ended
May 31, 2016
|
Nine months
ended
May 31, 2016
|
Three months
ended
May 31, 2015
|
Nine months
ended
May 31, 2015
|
|||||||||||||
Net earnings for the period
|
$
|
919
|
$
|
6,648
|
$
|
563
|
$
|
2,975
|
||||||||
Other comprehensive income (loss), net of income taxes
|
||||||||||||||||
Items that will not be reclassified subsequently to net earnings
|
||||||||||||||||
Foreign currency translation adjustment
|
5,488
|
775
|
802
|
(29,499
|
)
|
|||||||||||
Items that may be reclassified subsequently to net earnings
|
||||||||||||||||
Unrealized gains/losses on forward exchange contracts
|
1,045
|
825
|
38
|
(4,164
|
)
|
|||||||||||
Reclassification of realized losses on forward exchange contracts in net earnings
|
666
|
2,383
|
938
|
1,438
|
||||||||||||
Deferred income tax effect of gains/losses on forward exchange contracts
|
(434
|
)
|
(824
|
)
|
(270
|
)
|
725
|
|||||||||
Other comprehensive income (loss)
|
6,765
|
3,159
|
1,508
|
(31,500
|
)
|
|||||||||||
Comprehensive income (loss) for the period
|
$
|
7,684
|
$
|
9,807
|
$
|
2,071
|
$
|
(28,525
|
)
|
Nine months ended May 31, 2015
|
||||||||||||||||||||
Share
capital
|
Contributed surplus
|
Retained earnings
|
Accumulated other comprehensive loss
|
Total
shareholders' equity
|
||||||||||||||||
Balance as at September 1, 2014
|
$
|
111,491
|
$
|
16,503
|
$
|
113,635
|
$
|
(10,259
|
)
|
$
|
231,370
|
|||||||||
Redemption of share capital (note 5)
|
(26,396
|
)
|
1,222
|
–
|
–
|
(25,174
|
)
|
|||||||||||||
Reclassification of stock-based compensation costs (note 5)
|
1,376
|
(1,376
|
)
|
–
|
–
|
–
|
||||||||||||||
Stock-based compensation costs
|
–
|
1,175
|
–
|
–
|
1,175
|
|||||||||||||||
Net earnings for the period
|
–
|
–
|
2,975
|
–
|
2,975
|
|||||||||||||||
Other comprehensive loss
|
||||||||||||||||||||
Foreign currency translation adjustment
|
–
|
–
|
–
|
(29,499
|
)
|
(29,499
|
)
|
|||||||||||||
Changes in unrealized losses on forward exchange contracts, net of deferred income taxes of $725
|
–
|
–
|
–
|
(2,001
|
)
|
(2,001
|
)
|
|||||||||||||
Total comprehensive loss for the period
|
(28,525
|
)
|
||||||||||||||||||
Balance as at May 31, 2015
|
$
|
86,471
|
$
|
17,524
|
$
|
116,610
|
$
|
(41,759
|
)
|
$
|
178,846
|
Nine months ended May 31, 2016
|
||||||||||||||||||||
Share
capital
|
Contributed surplus
|
Retained earnings
|
Accumulated other comprehensive loss
|
Total
shareholders' equity
|
||||||||||||||||
Balance as at September 1, 2015
|
$
|
86,045
|
$
|
17,778
|
$
|
118,933
|
$
|
(52,005
|
)
|
$
|
170,751
|
|||||||||
Redemption of share capital (note 5)
|
(457
|
)
|
55
|
–
|
–
|
(402
|
)
|
|||||||||||||
Reclassification of stock-based compensation costs (note 5)
|
1,238
|
(1,238
|
)
|
–
|
–
|
–
|
||||||||||||||
Stock-based compensation costs
|
–
|
1,040
|
–
|
–
|
1,040
|
|||||||||||||||
Net earnings for the period
|
–
|
–
|
6,648
|
–
|
6,648
|
|||||||||||||||
Other comprehensive income
|
||||||||||||||||||||
Foreign currency translation adjustment
|
–
|
–
|
–
|
775
|
775
|
|||||||||||||||
Changes in unrealized gains/losses on forward exchange contracts, net of deferred income taxes of $824
|
–
|
–
|
–
|
2,384
|
2,384
|
|||||||||||||||
Total comprehensive income for the period
|
9,807
|
|||||||||||||||||||
Balance as at May 31, 2016
|
$
|
86,826
|
$
|
17,635
|
$
|
125,581
|
$
|
(48,846
|
)
|
$
|
181,196
|
Three months
ended
May 31, 2016
|
Nine months
ended
May 31, 2016
|
Three months
ended
May 31, 2015
|
Nine months
ended
May 31, 2015
|
|||||||||||||
Cash flows from operating activities
|
||||||||||||||||
Net earnings for the period
|
$
|
919
|
$
|
6,648
|
$
|
563
|
$
|
2,975
|
||||||||
Add (deduct) items not affecting cash
|
||||||||||||||||
Stock-based compensation costs
|
386
|
1,076
|
374
|
1,162
|
||||||||||||
Depreciation and amortization
|
1,252
|
3,737
|
1,607
|
6,225
|
||||||||||||
Deferred revenue
|
1,203
|
4,876
|
854
|
1,358
|
||||||||||||
Deferred income taxes
|
611
|
1,285
|
542
|
199
|
||||||||||||
Changes in foreign exchange gain/loss
|
626
|
(333
|
)
|
(77
|
)
|
(2,875
|
)
|
|||||||||
4,997
|
17,289
|
3,863
|
9,044
|
|||||||||||||
Changes in non-cash operating items
|
||||||||||||||||
Accounts receivable
|
(5,887
|
)
|
3,394
|
(6,494
|
)
|
(7,811
|
)
|
|||||||||
Income taxes and tax credits
|
(301
|
)
|
632
|
(541
|
)
|
(1,964
|
)
|
|||||||||
Inventories
|
(759
|
)
|
(6,627
|
)
|
950
|
(983
|
)
|
|||||||||
Prepaid expenses
|
(452
|
)
|
(418
|
)
|
(374
|
)
|
(875
|
)
|
||||||||
Other assets
|
‒
|
203
|
30
|
29
|
||||||||||||
Accounts payable, accrued liabilities and provisions
|
4,675
|
6,406
|
1,334
|
8,994
|
||||||||||||
Other liabilities
|
(5
|
)
|
(59
|
)
|
(30
|
)
|
(62
|
)
|
||||||||
2,268
|
20,820
|
(1,262
|
)
|
6,372
|
||||||||||||
Cash flows from investing activities
|
||||||||||||||||
Additions to short-term investments
|
(3,109
|
)
|
(3,130
|
)
|
‒
|
(19,509
|
)
|
|||||||||
Proceeds from disposal and maturity of short-term investments
|
‒
|
501
|
1,619
|
23,685
|
||||||||||||
Purchases capital assets
|
(1,138
|
)
|
(3,374
|
)
|
(1,826
|
)
|
(4,625
|
)
|
||||||||
(4,247
|
)
|
(6,003
|
)
|
(207
|
)
|
(449
|
)
|
|||||||||
Cash flows from financing activities
|
||||||||||||||||
Bank loan
|
‒
|
468
|
‒
|
‒
|
||||||||||||
Redemption of share capital (note 5)
|
(215
|
)
|
(402
|
)
|
(71
|
)
|
(25,174
|
)
|
||||||||
(215
|
)
|
66
|
(71
|
)
|
(25,174
|
)
|
||||||||||
Effect of foreign exchange rate changes on cash
|
1,049
|
1,526
|
78
|
(5,975
|
)
|
|||||||||||
Change in cash
|
(1,145
|
)
|
16,409
|
(1,462
|
)
|
(25,226
|
)
|
|||||||||
Cash – Beginning of the period
|
43,418
|
25,864
|
30,357
|
54,121
|
||||||||||||
Cash – End of the period
|
$
|
42,273
|
$
|
42,273
|
$
|
28,895
|
$
|
28,895
|
||||||||
Supplementary information
|
||||||||||||||||
Income taxes paid
|
$
|
505
|
$
|
1,621
|
$
|
350
|
$
|
1,174
|
||||||||
Additions to capital assets
|
$
|
1,011
|
$
|
3,386
|
$
|
1,700
|
$
|
4,638
|
1
|
Nature of Activities and Incorporation
|
2
|
Basis of Presentation
|
3
|
Restructuring Charges
|
4
|
Financial Instruments
|
Level 1: | Quoted prices (unadjusted) in active market for identical assets or liabilities |
Level 2: | Inputs other than quoted prices included within Level 1 that are observable for the asset and liability, either directly or indirectly |
Level 3: | Unobservable inputs for the asset or liability |
As at May 31, 2016
|
As at August 31, 2015
|
|||||||||||||||
Level 1
|
Level 2
|
Level 1
|
Level 2
|
|||||||||||||
Financial Assets
|
||||||||||||||||
Short-term investments
|
$
|
4,039
|
$
|
‒
|
$
|
1,487
|
$
|
‒
|
||||||||
Forward exchange contracts
|
$
|
‒
|
$
|
1,066
|
$
|
‒
|
$
|
‒
|
||||||||
Financial Liabilities
|
||||||||||||||||
Forward exchange contracts
|
$
|
‒
|
$
|
1,694
|
$
|
‒
|
$
|
4,154
|
Expiry dates
|
Contractual
amounts
|
Weighted average
contractual forward rates
|
|||||||
June 2016 to August 2016
|
$
|
6,300
|
1.2142
|
||||||
September 2016 to August 2017
|
22,200
|
1.2784
|
|||||||
September 2017 to August 2018
|
9,900
|
1.3367
|
|||||||
September 2018 to December 2018
|
1,900
|
1.3639
|
|||||||
Total
|
$
|
40,300
|
1.2867
|
Expiry dates
|
Contractual
amounts
|
Weighted average
contractual forward rates
|
|||||||
June 2016 to August 2016
|
$
|
1,000
|
67.88
|
||||||
September 2016 to May 2017
|
2,600
|
70.82
|
|||||||
Total
|
$
|
3,600
|
70.00
|
Three months
ended
May 31, 2016
|
Nine months
ended
May 31, 2016
|
Three months
ended
May 31, 2015
|
Nine months
ended
May 31, 2015
|
|||||||||||||
Losses on forward exchange contracts
|
$
|
438
|
$
|
2,287
|
$
|
878
|
$
|
1,770
|
5
|
Share Capital
|
Nine months ended May 31, 2015
|
||||||||||||||||||||
Multiple voting shares
|
Subordinate voting shares
|
|||||||||||||||||||
Number
|
Amount
|
Number
|
Amount
|
Total
Amount
|
||||||||||||||||
Balance as at September 1, 2014
|
31,643,000
|
$
|
1
|
28,703,750
|
$
|
111,490
|
$
|
111,491
|
||||||||||||
Redemption of restricted share units
|
−
|
−
|
115,669
|
−
|
−
|
|||||||||||||||
Redemption of share capital
|
−
|
−
|
(236,486
|
)
|
(919
|
)
|
(919
|
)
|
||||||||||||
Reclassification of stock-based compensation costs to share capital upon exercise of stock awards
|
−
|
−
|
−
|
443
|
443
|
|||||||||||||||
Balance as at November 30, 2014
|
31,643,000
|
1
|
28,582,933
|
111,014
|
111,015
|
|||||||||||||||
Redemption of restricted share units
|
−
|
−
|
107,099
|
−
|
−
|
|||||||||||||||
Redemption of deferred share units
|
−
|
−
|
48,697
|
−
|
−
|
|||||||||||||||
Redemption of share capital
|
−
|
−
|
(6,521,739
|
)
|
(25,395
|
)
|
(25,395
|
)
|
||||||||||||
Reclassification of stock-based compensation costs to share capital upon exercise of stock awards
|
–
|
–
|
–
|
907
|
907
|
|||||||||||||||
Balance as at February 28, 2015
|
31,643,000
|
1
|
22,216,990
|
86,526
|
86,527
|
|||||||||||||||
Redemption of restricted share units
|
−
|
−
|
5,636
|
−
|
−
|
|||||||||||||||
Redemption of share capital
|
−
|
−
|
(21,154
|
)
|
(82
|
)
|
(82
|
)
|
||||||||||||
Reclassification of stock-based compensation costs to share capital upon exercise of stock awards
|
–
|
–
|
–
|
26
|
26
|
|||||||||||||||
Balance as at May 31, 2015
|
31,643,000
|
$
|
1
|
22,201,472
|
$
|
86,470
|
$
|
86,471
|
Nine months ended May 31, 2016
|
||||||||||||||||||||
Multiple voting shares
|
Subordinate voting shares
|
|||||||||||||||||||
Number
|
Amount
|
Number
|
Amount
|
Total
amount
|
||||||||||||||||
Balance as at September 1, 2015
|
31,643,000
|
$
|
1
|
22,092,034
|
$
|
86,044
|
$
|
86,045
|
||||||||||||
Redemption of restricted share units
|
−
|
−
|
155,784
|
−
|
−
|
|||||||||||||||
Redemption of deferred share units
|
−
|
−
|
653
|
−
|
−
|
|||||||||||||||
Redemption of share capital
|
−
|
−
|
(200
|
)
|
(1
|
)
|
(1
|
)
|
||||||||||||
Reclassification of stock-based compensation costs to share capital upon exercise of stock awards
|
−
|
−
|
−
|
723
|
723
|
|||||||||||||||
Balance as at November 30, 2015
|
31,643,000
|
1
|
22,248,271
|
86,766
|
86,767
|
|||||||||||||||
Redemption of restricted share units
|
−
|
−
|
119,973
|
−
|
−
|
|||||||||||||||
Redemption of share capital
|
−
|
−
|
(62,442
|
)
|
(243
|
)
|
(243
|
)
|
||||||||||||
Reclassification of stock-based compensation costs to share capital upon exercise of stock awards
|
−
|
−
|
−
|
507
|
507
|
|||||||||||||||
Balance as at February 29, 2016
|
31,643,000
|
1
|
22,305,802
|
87,030
|
87,031
|
|||||||||||||||
Redemption of restricted share units
|
−
|
−
|
1,807
|
−
|
−
|
|||||||||||||||
Redemption of share capital
|
−
|
−
|
(54,369
|
)
|
(213
|
)
|
(213
|
)
|
||||||||||||
Reclassification of stock-based compensation costs to share capital upon exercise of stock awards
|
−
|
−
|
−
|
8
|
8
|
|||||||||||||||
Balance as at May 31, 2016
|
31,643,000
|
$
|
1
|
22,253,240
|
$
|
86,825
|
$
|
86,826
|
6
|
Statements of Earnings
|
Three months
ended
May 31, 2016
|
Nine months
ended
May 31, 2016
|
Three months
ended
May 31, 2015
|
Nine months
ended
May 31, 2015
|
|||||||||||||
Gross research and development expenses
|
$
|
12,612
|
$
|
35,363
|
$
|
12,462
|
$
|
37,947
|
||||||||
Research and development tax credits and grants
|
(1,309
|
)
|
(3,965
|
)
|
(1,539
|
)
|
(4,860
|
)
|
||||||||
Net research and development expenses for the period
|
$
|
11,303
|
$
|
31,398
|
$
|
10,923
|
$
|
33,087
|
Three months
ended
May 31, 2016
|
Nine months
ended
May 31, 2016
|
Three months
ended
May 31, 2015
|
Nine months
ended
May 31, 2015
|
|||||||||||||
Inventory write-down for the period
|
$
|
596
|
$
|
2,052
|
$
|
1,083
|
$
|
3,062
|
Three months
ended
May 31, 2016
|
Nine months
ended
May 31, 2016
|
Three months
ended
May 31, 2015
|
Nine months
ended
May 31, 2015
|
|||||||||||||
Cost of sales
|
||||||||||||||||
Depreciation of property, plant and equipment
|
$
|
325
|
$
|
960
|
$
|
367
|
$
|
1,136
|
||||||||
Amortization of intangible assets
|
179
|
524
|
243
|
1,355
|
||||||||||||
504
|
1,484
|
610
|
2,491
|
|||||||||||||
Selling and administrative expenses
|
||||||||||||||||
Depreciation of property, plant and equipment
|
125
|
385
|
124
|
401
|
||||||||||||
Amortization of intangible assets
|
19
|
55
|
69
|
771
|
||||||||||||
144
|
440
|
193
|
1,172
|
|||||||||||||
Net research and development expenses
|
||||||||||||||||
Depreciation of property, plant and equipment
|
508
|
1,512
|
672
|
2,127
|
||||||||||||
Amortization of intangible assets
|
96
|
301
|
132
|
435
|
||||||||||||
604
|
1,813
|
804
|
2,562
|
|||||||||||||
$
|
1,252
|
$
|
3,737
|
$
|
1,607
|
$
|
6,225
|
|||||||||
Depreciation of property, plant and equipment
|
$
|
958
|
$
|
2,857
|
$
|
1,163
|
$
|
3,664
|
||||||||
Amortization of intangible assets
|
294
|
880
|
444
|
2,561
|
||||||||||||
Total depreciation and amortization expenses for the period
|
$
|
1,252
|
$
|
3,737
|
$
|
1,607
|
$
|
6,225
|
Three months
ended
May 31, 2016
|
Nine months
ended
May 31, 2016
|
Three months
ended
May 31, 2015
|
Nine months
ended
May 31, 2015
|
|||||||||||||
Salaries and benefits
|
$
|
28,983
|
$
|
83,741
|
$
|
28,724
|
$
|
88,031
|
||||||||
Stock-based compensation costs
|
386
|
1,076
|
374
|
1,162
|
||||||||||||
Total employee compensation for the period
|
$
|
29,369
|
$
|
84,817
|
$
|
29,098
|
$
|
89,193
|
Three months
ended
May 31, 2016
|
Nine months
ended
May 31, 2016
|
Three months
ended
May 31, 2015
|
Nine months
ended
May 31, 2015
|
|||||||||||||
Cost of sales
|
$
|
25
|
$
|
80
|
$
|
43
|
$
|
126
|
||||||||
Selling and administrative expenses
|
285
|
775
|
247
|
770
|
||||||||||||
Net research and development expenses
|
76
|
221
|
84
|
266
|
||||||||||||
Total stock-based compensation for the period
|
$
|
386
|
$
|
1,076
|
$
|
374
|
$
|
1,162
|
7
|
Income Taxes
|
Three months
ended
May 31, 2016
|
Nine months
ended
May 31, 2016
|
Three months
ended
May 31, 2015
|
Nine months
ended
May 31, 2015
|
|||||||||||||
Income tax provision at combined Canadian federal and provincial statutory tax rate (27%)
|
$
|
814
|
$
|
3,300
|
$
|
613
|
$
|
1,737
|
||||||||
Increase (decrease) due to:
|
||||||||||||||||
Foreign income taxed at different rates
|
(212
|
)
|
(612
|
)
|
223
|
800
|
||||||||||
Non-taxable (income)/loss
|
(203
|
)
|
(273
|
)
|
14
|
1,088
|
||||||||||
Non-deductible expenses
|
171
|
486
|
186
|
560
|
||||||||||||
Foreign exchange effect of translation of foreign subsidiaries in the functional currency
|
227
|
328
|
(280
|
)
|
(3,399
|
)
|
||||||||||
Utilization of previously unrecognized deferred income tax assets
|
32
|
−
|
74
|
(6
|
)
|
|||||||||||
Unrecognized deferred income tax assets on temporary deductible differences and unused tax losses
|
1,340
|
2,682
|
926
|
2,909
|
||||||||||||
Other
|
(73
|
)
|
(335
|
)
|
(49
|
)
|
(231
|
)
|
||||||||
Income tax provision for the period
|
$
|
2,096
|
$
|
5,576
|
$
|
1,707
|
$
|
3,458
|
Three months
ended
May 31, 2016
|
Nine months
ended
May 31, 2016
|
Three months
ended
May 31, 2015
|
Nine months
ended
May 31, 2015
|
|||||||||||||
Current
|
$
|
1,485
|
$
|
4,291
|
$
|
1,165
|
$
|
3,259
|
||||||||
Deferred
|
611
|
1,285
|
542
|
199
|
||||||||||||
$
|
2,096
|
$
|
5,576
|
$
|
1,707
|
$
|
3,458
|
8
|
Earnings per Share
|
Three months
ended
May 31, 2016
|
Nine months
ended
May 31, 2016
|
Three months
ended
May 31, 2015
|
Nine months
ended
May 31, 2015
|
|||||||||||||
Basic weighted average number of shares outstanding (000s)
|
53,940
|
53,894
|
53,861
|
57,804
|
||||||||||||
Plus dilutive effect of (000s):
|
||||||||||||||||
Restricted share units
|
735
|
635
|
597
|
545
|
||||||||||||
Deferred share units
|
138
|
126
|
91
|
104
|
||||||||||||
Diluted weighted average number of shares outstanding (000s)
|
54,813
|
54,655
|
54,549
|
58,453
|
||||||||||||
Stock awards excluded from the calculation of diluted weighted average number of shares because their exercise price was greater than the average market price of the common shares (000s)
|
−
|
101
|
20
|
65
|
Three months
ended
May 31, 2016
|
Three months
ended
May 31, 2015
|
Nine months
ended
May 31, 2016
|
Nine months
ended
May 31, 2015
|
|||||||||||||
Sales
|
$
|
60,896
|
$
|
57,781
|
$
|
169,725
|
$
|
165,495
|
||||||||
Cost of sales (1)
|
23,880
|
22,281
|
62,921
|
63,064
|
||||||||||||
Selling and administrative
|
20,798
|
20,489
|
60,615
|
61,689
|
||||||||||||
Net research and development
|
11,303
|
10,923
|
31,398
|
33,087
|
||||||||||||
Depreciation of property, plant and equipment
|
958
|
1,163
|
2,857
|
3,664
|
||||||||||||
Amortization of intangible assets
|
294
|
444
|
880
|
2,561
|
||||||||||||
Interest and other (income) expense
|
(309
|
)
|
36
|
(716
|
)
|
(216
|
)
|
|||||||||
Foreign exchange (gain) loss
|
957
|
175
|
(454
|
)
|
(4,787
|
)
|
||||||||||
Earnings before income taxes
|
3,015
|
2,270
|
12,224
|
6,433
|
||||||||||||
Income taxes
|
2,096
|
1,707
|
5,576
|
3,458
|
||||||||||||
Net earnings for the period
|
$
|
919
|
$
|
563
|
$
|
6,648
|
$
|
2,975
|
||||||||
Basic and diluted net earnings per share
|
$
|
0.02
|
$
|
0.01
|
$
|
0.12
|
$
|
0.05
|
||||||||
Other selected information:
|
||||||||||||||||
Gross margin before depreciation and amortization (2)
|
$
|
37,016
|
$
|
35,500
|
$
|
106,804
|
$
|
102,431
|
||||||||
Research and development:
|
||||||||||||||||
Gross research and development
|
$
|
12,612
|
$
|
12,462
|
$
|
35,363
|
$
|
37,947
|
||||||||
Net research and development
|
$
|
11,303
|
$
|
10,923
|
$
|
31,398
|
$
|
33,087
|
||||||||
Adjusted EBITDA (2)
|
$
|
5,301
|
$
|
4,462
|
$
|
15,867
|
$
|
8,817
|
(1)
|
The cost of sales is exclusive of depreciation and amortization, shown separately.
|
(2)
|
Refer to page 34 for non-IFRS measures.
|
Three months
ended
May 31, 2016
|
Three months
ended
May 31, 2015
|
Nine months
ended
May 31, 2016
|
Nine months
ended
May 31, 2015
|
|||||||||||||
Sales
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
||||||||
Cost of sales (1)
|
39.2
|
38.6
|
37.1
|
38.1
|
||||||||||||
Selling and administrative
|
34.2
|
35.5
|
35.7
|
37.3
|
||||||||||||
Net research and development
|
18.6
|
18.9
|
18.5
|
20.0
|
||||||||||||
Depreciation of property, plant and equipment
|
1.5
|
2.0
|
1.7
|
2.2
|
||||||||||||
Amortization of intangible assets
|
0.5
|
0.8
|
0.5
|
1.5
|
||||||||||||
Interest and other (income) expense
|
(0.5
|
)
|
−
|
(0.4
|
)
|
(0.1
|
)
|
|||||||||
Foreign exchange (gain) loss
|
1.5
|
0.3
|
(0.3
|
)
|
(2.9
|
)
|
||||||||||
Earnings before income taxes
|
5.0
|
3.9
|
7.2
|
3.9
|
||||||||||||
Income taxes
|
3.5
|
2.9
|
3.3
|
2.1
|
||||||||||||
Net earnings for the period
|
1.5
|
%
|
1.0
|
%
|
3.9
|
%
|
1.8
|
%
|
||||||||
Other selected information:
|
||||||||||||||||
Gross margin before depreciation and amortization (2)
|
60.8
|
%
|
61.4
|
%
|
62.9
|
%
|
61.9
|
%
|
||||||||
Research and development:
|
||||||||||||||||
Gross research and development
|
20.7
|
%
|
21.6
|
%
|
20.8
|
%
|
22.9
|
%
|
||||||||
Net research and development
|
18.6
|
%
|
18.9
|
%
|
18.5
|
%
|
20.0
|
%
|
||||||||
Adjusted EBITDA (2)
|
8.7
|
%
|
7.7
|
%
|
9.3
|
%
|
5.3
|
%
|
(1)
|
The cost of sales is exclusive of depreciation and amortization, shown separately.
|
(2)
|
Refer to page 34 for non-IFRS measures.
|
Three months
ended
May 31, 2016
|
Three months
ended
May 31, 2015
|
Nine months
ended
May 31, 2016
|
Nine months
ended
May 31, 2015
|
|||||||||||||
Physical-layer product line
|
$
|
42,074
|
$
|
38,167
|
$
|
112,133
|
$
|
109,074
|
||||||||
Protocol-layer product line
|
19,260
|
20,492
|
59,879
|
58,191
|
||||||||||||
61,334
|
58,659
|
172,012
|
167,265
|
|||||||||||||
Foreign exchange losses on forward exchange contracts
|
(438
|
)
|
(878
|
)
|
(2,287
|
)
|
(1,770
|
)
|
||||||||
Total sales
|
$
|
60,896
|
$
|
57,781
|
$
|
169,725
|
$
|
165,495
|
Three months
ended
May 31, 2016
|
Three months
ended
May 31, 2015
|
Nine months
ended
May 31, 2016
|
Nine months
ended
May 31, 2015
|
|||||||||||||
Physical-layer product line
|
$
|
41,797
|
$
|
38,534
|
$
|
115,549
|
$
|
109,151
|
||||||||
Protocol-layer product line
|
18,389
|
21,593
|
64,662
|
60,762
|
||||||||||||
60,186
|
60,127
|
180,211
|
169,913
|
|||||||||||||
Foreign exchange losses on forward exchange contracts
|
(438
|
)
|
(878
|
)
|
(2,287
|
)
|
(1,770
|
)
|
||||||||
Total bookings
|
$
|
59,748
|
$
|
59,249
|
$
|
177,924
|
$
|
168,143
|
Three months
ended
May 31, 2016
|
Three months
ended
May 31, 2015
|
Nine months
ended
May 31, 2016
|
Nine months
ended
May 31, 2015
|
|||||||||
Americas
|
59
|
%
|
58
|
%
|
55
|
%
|
53
|
%
|
||||
EMEA
|
22
|
23
|
25
|
27
|
||||||||
APAC
|
19
|
19
|
20
|
20
|
||||||||
100
|
%
|
100
|
%
|
100
|
%
|
100
|
%
|
Expiry dates
|
Contractual
amounts
|
Weighted average
contractual
forward rates
|
||||||
June 2016 to August 2016
|
$
|
6,300,000
|
1.2142
|
|||||
September 2016 to August 2017
|
22,200,000
|
1.2784
|
||||||
September 2017 to August 2018
|
9,900,000
|
1.3367
|
||||||
September 2018 to December 2018
|
1,900,000
|
1.3639
|
||||||
Total
|
$
|
40,300,000
|
1.2867
|
Expiry dates
|
Contractual
amounts
|
Weighted average
contractual
forward rates
|
||||||
June 2016 to August 2016
|
$
|
1,000,000
|
67.88
|
|||||
September 2016 to May 2017
|
2,600,000
|
70.82
|
||||||
$
|
3,600,000
|
70.00
|
Three months
ended
May 31, 2016
|
Three months
ended
May 31, 2015
|
Nine months
ended
May 31, 2016
|
Nine months
ended
May 31, 2015
|
|||||||||||||
IFRS net earnings for the period
|
$
|
919
|
$
|
563
|
$
|
6,648
|
$
|
2,975
|
||||||||
Add (deduct):
|
||||||||||||||||
Depreciation of property, plant and equipment
|
958
|
1,163
|
2,857
|
3,664
|
||||||||||||
Amortization of intangible assets
|
294
|
444
|
880
|
2,561
|
||||||||||||
Interest and other (income) expense
|
(309
|
)
|
36
|
(716
|
)
|
(216
|
)
|
|||||||||
Income taxes
|
2,096
|
1,707
|
5,576
|
3,458
|
||||||||||||
Stock-based compensation costs
|
386
|
374
|
1,076
|
1,162
|
||||||||||||
Foreign exchange (gain) loss
|
957
|
175
|
(454
|
)
|
(4,787
|
)
|
||||||||||
Adjusted EBITDA for the period
|
$
|
5,301
|
$
|
4,462
|
$
|
15,867
|
$
|
8,817
|
||||||||
Adjusted EBITDA in percentage of sales
|
8.7
|
%
|
7.7
|
%
|
9.3
|
%
|
5.3
|
%
|
Quarters ended
|
||||||||||||||||
May 31,
2016
|
February 29,
2016
|
November 30,
2015
|
August 31,
2015
|
|||||||||||||
Sales
|
$
|
60,896
|
$
|
53,597
|
$
|
55,232
|
$
|
56,594
|
||||||||
Cost of sales (1)
|
$
|
23,880
|
$
|
18,904
|
$
|
20,137
|
$
|
21,975
|
||||||||
Net earnings
|
$
|
919
|
$
|
3,963
|
$
|
1,766
|
$
|
2,323
|
||||||||
Basic and diluted net earnings per share
|
$
|
0.02
|
$
|
0.07
|
$
|
0.03
|
$
|
0.04
|
Quarters ended
|
||||||||||||||||
May 31,
2015
|
February 28,
2015
|
November 30,
2014
|
August 31,
2014
|
|||||||||||||
Sales
|
$
|
57,781
|
$
|
50,990
|
$
|
56,724
|
$
|
59,742
|
||||||||
Cost of sales (1)
|
$
|
22,281
|
$
|
19,546
|
$
|
21,237
|
$
|
22,109
|
||||||||
Net earnings
|
$
|
563
|
$
|
931
|
$
|
1,481
|
$
|
1,204
|
||||||||
Basic and diluted net earnings per share
|
$
|
0.01
|
$
|
0.02
|
$
|
0.02
|
$
|
0.02
|
(1)
|
The cost of sales is exclusive of depreciation and amortization.
|